Edition:
United Kingdom

China Grand Pharmaceutical and Healthcare Holdings Ltd (0512.HK)

0512.HK on Hong Kong Stock

5.23HKD
23 Jul 2018
Change (% chg)

HK$-0.06 (-1.13%)
Prev Close
HK$5.29
Open
HK$5.20
Day's High
HK$5.28
Day's Low
HK$5.19
Volume
1,964,000
Avg. Vol
4,578,048
52-wk High
HK$6.99
52-wk Low
HK$2.05

Latest Key Developments (Source: Significant Developments)

Sirtex Medical Updates On Payment Of A$15.8 Mln Break Fee To Varian
Thursday, 12 Jul 2018 

July 13 (Reuters) - Sirtex Medical Ltd ::PAYMENT OF A$15.8 MILLION BREAK FEE TO VARIAN.CONFIRMS HAS RECEIVED CASH REIMBURSEMENT FROM CDH-CGP EQUIVALENT TO AMOUNT PAID TO VARIAN.  Full Article

China Grand Pharmaceutical And Healthcare Sees Consol Net Profit Attributable To Increase
Thursday, 12 Jul 2018 

July 12 (Reuters) - China Grand Pharmaceutical and Healthcare Holdings Ltd <0512.HK>::EXPECTED THAT HY UNAUDITED CONSOLIDATED NET PROFIT ATTRIBUTABLE RECORDED AN INCREASE OF NOT LESS THAN 50%.SEES UNAUDITED CONSOL NET PROFIT ATTRIBUTABLE TO INCREASE BY NOT LESS THAN 50% FOR HY.EXPECTED RESULT DUE TO CONTRIBUTION OF MID-TO-LONG TERM DEVELOPMENT STRATEGY OF GROUP .  Full Article

China Grand Pharmaceutical And Healthcare To Raise Up To HK$2.88 Bln Via Share Issuance
Wednesday, 4 Jul 2018 

July 4 (Reuters) - China Grand Pharmaceutical and Healthcare Holdings Ltd <0512.HK>::CO TO RAISE UP TO HK$2,879.12 MILLION BY ISSUING UP TO 553.7 MILLION RIGHTS SHARES.DEAL AT HK$5.20 PER RIGHTS SHARE.INTENDS TO USE HK$2.80 BILLION TO PAY CO'S CONTRIBUTION IN RELATION TO CO'S PROPOSED ACQUISITION OF SIRTEX.  Full Article

Sirtex Medical Gets FIRB Approval
Tuesday, 3 Jul 2018 

July 3 (Reuters) - Sirtex Medical Ltd ::COMMONWEALTH TREASURER HAS NO OBJECTION TO ENTITY OWNED BY CDH FUND V, L.P. AND CHINA GRAND PHARMACEUTICAL AND HEALTHCARE ACQUIRING SIRTEX.  Full Article

China Grand Pharmaceutical And Healthcare To Issue 237.4 Mln Shares For Hk$1.23 Bln
Thursday, 31 May 2018 

June 1 (Reuters) - China Grand Pharmaceutical and Healthcare Holdings Ltd <0512.HK>::CHINA GRAND PHARMACEUTICAL AND HEALTHCARE -TO ISSUE 237.4 MILLION SHARES FOR HK$1.23 BILLION TO SHANGHAI CHINA GRAND ASSET FINANCE INVESTMENT MANAGEMENT CO.CHINA GRAND PHARMACEUTICAL AND HEALTHCARE -NEGOTIATION WITH CERTAIN POTENTIAL PLACING AGENTS IFOR POSSIBLE PLACING OF HK$681.2 MILLION.COMPANY EXPECTS TO RAISE GROSS PROCEEDS OF APPROXIMATELY HK$2,375.3 MILLION.  Full Article

China Grand Pharmaceutical And Healthcare Gets ‍Drug Clinical Trial Approval Document From China FDA For Products
Thursday, 28 Dec 2017 

Dec 28 (Reuters) - China Grand Pharmaceutical And Healthcare Holdings Ltd <0512.HK>::CHINA GRAND PHARMACEUTICAL AND HEALTHCARE HOLDINGS- ‍"BIMATOPROST OPHTHALMIC SOLUTION" OBTAINED DRUG CLINICAL TRIAL APPROVAL DOCUMENT FROM CHINA FDA.  Full Article

China Grand Pharmaceutical and Healthcare announces ‍subscription of shares of Conavi Medical
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - China Grand Pharmaceutical And Healthcare Holdings Ltd <0512.HK>::Announces ‍subscription of shares of medical devices company in Canada​.JV will subscribe to 1 million preferred shares of Conavi Medical for US$7.5 million​.  Full Article

China Grand Pharmaceutical and Healthcare Holdings says to establish JV co
Monday, 13 Nov 2017 

Nov 13 (Reuters) - China Grand Pharmaceutical And Healthcare Holdings Ltd <0512.HK>:Co and East Ocean Capital agreed to establish JV in Hong Kong.‍Total investment in JV will be about US$15 million​.  Full Article

China Grand Pharmaceutical and Healthcare unit enters acquisition agreement​
Tuesday, 10 Oct 2017 

Oct 10 (Reuters) - China Grand Pharmaceutical And Healthcare Holdings Ltd <0512.HK>:Unit, Huang Xiaohua and Xian Beilin Pharmaceutical co entered into beilin acquisition agreement​.‍Deal for consideration of RMB131.5 million to be satisfied in cash​.Unit to acquire 22.8% of share capital in Xian Beilin Pharmaceutical​.  Full Article

Australia's Sirtex clears U.S. regulatory hurdle for Chinese buyout

Liver cancer treatment maker Sirtex Medical said on Monday that the U.S. Federal Trade Commission cleared its $1.4 billion buyout by a Chinese consortium, clearing a major hurdle for the deal to go through.